High Definition Profiling of Ovarian Cancer Ascites
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorEuropean Institute of Oncology
About this trial
This project entails the collection of a prospective cohort of ascites (AS) samples from High Grade Serous Ovarian Cancer (HGSOC) patients.
High Grade Serous Ovarian Cancer (HGSOC) is a major cause of cancer-related mortality, due to the late-stage diagnosis and failure of surgery and chemotherapy (CHT) to eradicate the disease with no significant improvement in overall survival.
The primary objective of the project is to generate a comprehensive map of ascites cell components, detailing both their intrinsic features and the landscape of cellular interactions mediated by soluble factors in ascitic fluid.
Eligibility criteria
Qualifiers
Patients with suspicious or confirmed ovarian cancer pathology undergoing debulking surgery
Diagnosis of high grade serous ovarian cancer confirmed by histopathology assessment
Patients who provided written informed consent
Disqualifiers
HIV-positive patients
HBV-positive patients
HCV-positive patients
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov